ストックスクリーナーアプリを入手
6.16
3.53%
0.21
前日終値:
$5.95
開ける：
$6.08
24時間の取引高:
5.07M
Relative Volume:
1.06
時価総額：
$1.19B
収益：
$71.80M
当期純損益:
$-183.59M
株価収益率:
-5.8427
EPS:
-1.0543
ネットキャッシュフロー:
$-186.52M
1週間 パフォーマンス:
+6.02%
1か月 パフォーマンス:
-3.75%
6か月 パフォーマンス:
-60.36%
1年 パフォーマンス:
-10.72%
1日の値動き範囲:
$6.00
$6.265
1週間の範囲:
$5.715
$6.265
52週間の値動き範囲:
$5.02
$21.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Compare WVE vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
6.16 | 1.19B | 71.80M | -183.59M | -186.52M | -1.0543 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-05 | 開始されました | BofA Securities | Buy |
| 2025-12-12 | 繰り返されました | Wedbush | Outperform |
| 2025-12-09 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-20 | 開始されました | Wells Fargo | Overweight |
| 2025-08-04 | 開始されました | Canaccord Genuity | Buy |
| 2025-07-28 | 開始されました | Oppenheimer | Outperform |
| 2025-07-16 | 開始されました | Citigroup | Buy |
| 2025-06-11 | 再開されました | Raymond James | Outperform |
| 2025-04-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 開始されました | Wedbush | Outperform |
| 2025-02-25 | 開始されました | Jefferies | Buy |
| 2024-10-16 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | 再開されました | JP Morgan | Overweight |
| 2024-09-19 | 開始されました | B. Riley Securities | Buy |
| 2024-09-09 | 開始されました | JP Morgan | Overweight |
| 2024-05-15 | 開始されました | Wells Fargo | Overweight |
| 2023-12-19 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | 開始されました | Raymond James | Outperform |
| 2023-05-24 | ダウングレード | Jefferies | Buy → Hold |
| 2020-12-15 | 再開されました | H.C. Wainwright | Buy |
| 2020-10-23 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | 開始されました | Guggenheim | Buy |
| 2019-07-15 | 開始されました | Cowen | Market Perform |
| 2019-04-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-08-07 | 開始されました | Stifel | Buy |
| 2018-07-23 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-19 | 繰り返されました | Mizuho | Buy |
| 2017-02-15 | 開始されました | H.C. Wainwright | Buy |
| 2016-11-10 | 再開されました | Leerink Partners | Outperform |
| 2015-12-07 | 開始されました | JMP Securities | Mkt Outperform |
| 2015-12-07 | 開始されました | Jefferies | Buy |
| 2015-12-07 | 開始されました | Leerink Partners | Outperform |
| 2015-12-07 | 開始されました | Sun Trust Rbsn Humphrey | Buy |
すべてを表示
Wave Life Sciences Ltd (WVE) 最新ニュース
Price-Driven Insight from (WVE) for Rule-Based Strategy - Stock Traders Daily
ARWR Stock Slid Lower Today — What Does Wave Life Sciences Have To Do With It? - Stocktwits
The Bull Case For Wave Life Sciences (WVE) Could Change Following A Zacks Earnings-Estimate Upgrade - simplywall.st
WAVE Life Sciences Ltd (WVE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
WAVE Life Sciences Ltd (WVE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
WAVE Life Sciences Ltd (WVE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
WAVE Life Sciences Ltd (WVE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
WAVE Life Sciences Ltd (WVE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
WAVE Life Sciences Ltd (WVE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Wave Life Sciences (WVE) Stock Could Be 73% Undervalued After WVE 006 Data - simplywall.st
Wave Life Sciences (WVE) Upgraded to Buy: Here's Why - Yahoo Finance
WAVE Life Sciences Ltd (WVE) Institutional Confidence - TradingKey
Wave Life Sciences Ltd. (WVE) stock price, news, quote and history - Yahoo Finance UK
Is Wave Life Sciences Ltd. (WVE) A Good Stock To Buy Now? - Insider Monkey
What Went Wrong For WVE? The Obesity Drug Trial Data That Spooked Investors - Stocktwits
WVE News | WAVE LIFE SCIENCES LTD (NASDAQ:WVE) - ChartMill
Failed Obesity Trial And Investor Exit Might Change The Case For Investing In Wave Life Sciences (WVE) - Sahm
Inside Wells Fargo’s Take on Wave Life Sciences Ltd (WVE) Stock - Insider Monkey
H.C. Wainwright Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $13 - Moomoo
Billionaire Lee Ainslie’s 5 Stocks with Huge Upside Potential - Insider Monkey
WVE Stock Price, Quote & Chart - ChartMill
(WVE) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Transcript : Wave Life Sciences Ltd. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 08 - marketscreener.com
WVE: WVE-007 advances to phase II-A for obesity, with RNA editing programs nearing key milestones - TradingView
Wave Life Sciences (WVE) Valuation After Obesity Drug Setback And Institutional Investor Exit - simplywall.st
Wave Life Sciences Faces Setback As WVE-007 Fails And Investor Exits - simplywall.st
WAVE LIFE SCIENCES LTD (WVE) Stock Chart - ChartMill
Wave Life Sciences Hits Day Low at $5.65 Amid Price Pressure - MarketsMojo
AI’s rising power demand brings wave energy to NVIDIA GTC stage - Stock Titan
Wave Life Sciences to Present at Upcoming Investor Conferences - The Manila Times
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter - AOL.com
Is RNA Editor WVE-006’s MZ-Like AAT Restoration Altering The Investment Case For Wave Life Sciences (WVE)? - simplywall.st
Wave Life Science prices upsized $350M stock ofeering - MSN
Wells Fargo Maintains Wave Life Sciences (WVE) Overweight Recommendation - MSN
(WVE) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
EDGAR Filing Documents for 0001193125-25-044876 - SEC.gov
Wedbush Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Investigation launched into Wave Life Sciences over possible securities law violations after stock drop - Pluang
Wave Life Sciences Ltd. Shareholders Are Encouraged to - GlobeNewswire
Wave Life Sciences(WVE) Stock Options Chain | Quotes & News - Moomoo
Should WVE-006’s RNA-Editing AAT Data Shift the Risk-Reward Calculus for Wave Life Sciences (WVE) Investors? - Yahoo Finance
Wave Life Sciences (WVE) Valuation Check After Sharp Share Price Weakness - simplywall.st
WAVE Life Sciences Analyst Ratings and Price Targets | NASDAQ:WVE - Benzinga
Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Wave Life Sciences (WVE) Is Down 11.4% After Positive WVE-006 AATD Data and Accelerated Path Update - simplywall.st
Wave Life Sciences: 'Strong Buy' On DMD NDA Filing WVE-N531 And Released AATD Data - Seeking Alpha
WVE Maintained by Wells Fargo -- Price Target Raised to $14.00 - GuruFocus
Wave Life Sciences Is Maintained at Overweight by Wells Fargo - Moomoo
CCORF Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $43 - Moomoo
WVE: Advancing siRNA and RNA editing therapies with strong clinical data and regulatory momentum - TradingView
Wells Fargo raises Wave Life Sciences price target on AATD data - Investing.com Australia
Wave Life Sciences Ltd (WVE) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
1.44%
大文字化:
|
ボリューム (24 時間):